Phase 1/2 Study of BDTX-1535 in Patients with Glioblastoma or Non-Small Cell Lung Cancer with EGFR Mutations
Study testing BDTX-1535 for glioblastoma and lung cancer with EGFR mutations.
Recruiting
18 years and older
All
Phase 1/2
Simplified description (AI rewritten)
Technical description (Original)
This study focuses on a new drug, **BDTX-1535**, to treat *glioblastoma* (a type of brain cancer) and **non-small cell lung cancer (NSCLC)** with specific *epidermal growth factor receptor (EGFR)* mutations. The study is divided into two phases. Phase 1 is complete, while Phase 2 is open for enrollment. Patients will take the drug by mouth in 21-day cycles. The study aims to find the safest dose and see how the drug works in the body and against cancer.
**Key points to consider:**
- **Study Length & Visits**: Participation involves taking the medication at home and regular check-ups.
- **Eligibility**: Must have advanced NSCLC with specific EGFR mutations or glioblastoma.
- **Risks & Benefits**: Understand potential side effects and possible benefits of trying a new treatment.
Participants need to have a confirmed diagnosis of NSCLC or glioblastoma and must meet specific criteria related to past treatments and current health status. Some conditions such as certain prior treatments, other health issues, or active infections could exclude participation. If considering this study, discuss with your doctor to understand all the details and implications.
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
Enable functional cookies in order to access shared annotations.
The passcode will expire in None.
Loading...
No annotations made yet
Add a private note
Select a piece of text from the left.
Add notes visible only to you.
Send it to people through a passcode protected link.
Send Notes
Loading...
Publish Annotation
Are you sure you want to publish the annotation?
Delete
Are you sure you want to delete the ?
FAQs
Learn more about clinical trials
What is a clinical trial?
A clinical trial is a study designed to test specific
interventions or treatments' effectiveness and safety,
paving the way for new, innovative healthcare solutions.
Why should I take part in a clinical trial?
Participating in a clinical trial provides early access to
potentially effective treatments and directly contributes to
the healthcare advancements that benefit us all.
How long does a clinical trial take place?
The duration of clinical trials varies. Some trials last
weeks, some years, depending on the phase and intention of
the trial.
Do I get compensated for taking part in clinical
trials?
Compensation varies per trial. Some offer payment or
reimbursement for time and travel, while others may not.
How safe are clinical trials?
Clinical trials follow strict ethical guidelines and
protocols to safeguard participants' health. They are
closely monitored and safety reviewed regularly.